LRP1B encodes low-density lipoprotein receptor-related protein 1b, and its mutations were recently found to be associated with improved efficacy of ICI in NSCLC (He et al. 2023; Yu et al. 2022). Here, LRP1B is linked to non-small cell lung carcinoma.